These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33530081)

  • 1. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
    Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
    Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
    Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
    Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
    Yu JN; Wu BB; Yang J; Lei XL; Shen WQ
    Biol Res Nurs; 2021 Apr; 23(2):258-269. PubMed ID: 32851851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study.
    Fathi M; Vakili K; Sayehmiri F; Mohamadkhani A; Hajiesmaeili M; Rezaei-Tavirani M; Eilami O
    PLoS One; 2021; 16(2):e0246190. PubMed ID: 33592019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiovascular and metabolic diseases on the severity of COVID-19: a systematic review and meta-analysis.
    Meng M; Zhao Q; Kumar R; Bai C; Deng Y; Wan B
    Aging (Albany NY); 2020 Nov; 12(22):23409-23421. PubMed ID: 33199670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: A systematic review and meta-analysis without cases duplication.
    Wang Z; Deng H; Ou C; Liang J; Wang Y; Jiang M; Li S
    Medicine (Baltimore); 2020 Nov; 99(48):e23327. PubMed ID: 33235096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
    Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cerebrovascular disease as a comorbidity in patients with COVID-19: A meta-analysis.
    Zhang J; Wang H; Wei M; Zhang H; Xia B; Wang X; Pei Y; Dong L; Li Y
    Aging (Albany NY); 2020 Nov; 12(23):23450-23463. PubMed ID: 33221757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.
    Sahni S; Gupta G; Sarda R; Pandey S; Pandey RM; Sinha S
    Diabetes Metab Syndr; 2021; 15(6):102308. PubMed ID: 34673359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Comorbidities on the Infection Rate and Severity of COVID-19: Nationwide Cohort Study With Propensity Score Matching.
    Kim J; Park SH; Kim JM
    JMIR Public Health Surveill; 2022 Nov; 8(11):e35025. PubMed ID: 36265125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis.
    Parveen R; Sehar N; Bajpai R; Agarwal NB
    Diabetes Res Clin Pract; 2020 Aug; 166():108295. PubMed ID: 32623032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis.
    Giri M; Puri A; Wang T; Guo S
    Sci Prog; 2021; 104(1):368504211000906. PubMed ID: 33752530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
    PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
    Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
    Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.